Table 4.
List of nucleic acid-based diagnostic tools developed on the basis of emergency use authorized by FDA [79].
| Source | Mechanism of Detection | Site/antibody Target | Time limit | Detection limit | Point of care |
|---|---|---|---|---|---|
| Thermo Fisher | qReverse transcriptase -PCR | Open reading frame1ab, Nucleoprtein coding gene, Surface protein coding-gene | >2h | 10 copies/microliter | no |
| Roche | qReverse transcriptase -PCR | Open reading frame 1a | >2h | 9 copies/microliter | no |
| PerkinElmer | qReverse transcriptase -PCR | Open reading frame 1 ab, Nucleoprotein coding gene | >2h | 0.025 copies/microliter | no |
| Sherlock Bioscience | CRISPR + LFA | Surface protein-coding gene, Open reading frame1ab | 60 min | 10-100 copies/microliter | yes |
| Cepheid | qReverse transcriptase -PCR | Nucleoprotein coding gene, Envelope protein coding-gene | 45 min | 0.25 copies/microliter | yes |
| BioFire | qReverse transcriptase -PCR | Open reading frame 8, Open reading frame 1 ab | 50 min | 0.33 copies/microliter | yes |
| Mesa Biotech | Reverse transcriptase -PCR + LFA | Nucleoprotein coding gene | 30 min | 200 copies/reaction | yes |
| Abbott | Isothermal nucleic acid amplification | RNA dependent RNA polymerase-gene | 5/13 min | 0.125 copies/microliter | yes |
| CDC | qReverse transcriptase -PCR | Nucleoprotein coding gene | >2h | 3.2 copies/microliter | no |
| Mammoth Bioscience | CRISPR + LFA | Envelope protein-coding gene, Nucleoprtein gene | 30 min | 70-300 copies/microliter | yes |